CYTEK BIOSCIENCES, INC. (CTKB) Revenue 2020–2025
CYTEK BIOSCIENCES, INC. (CTKB) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$201.5MFY2025 · since FY2020: $92.8M → $201.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $201.5M | +0.5% |
| FY2024 | $200.5M | +3.9% |
| FY2023 | $193.0M | +17.7% |
| FY2022 | $164.0M | +28.2% |
| FY2021 | $128.0M | +37.8% |
| FY2020 | $92.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTKB financial trends
CTKB Net incomeCTKB Net marginCTKB Gross profitCTKB Gross marginCTKB Operating incomeCTKB Operating marginCTKB Operating cash flowCTKB Free cash flowCTKB Capital expendituresCTKB Return on equityCTKB Stock buybacksCTKB Dividends paidCTKB Total assetsCTKB Total liabilitiesCTKB Shareholders’ equityCTKB overview →